The UMD-DMD France mutations database
Record ID: 1605

Mutation description


Variation name (cDNA level)Variation name (protein level)Variation statusVariation class
c.IVS65-2A>T (c.9564-2A>T)HemizygousMutation

wt codonwt aamutant codonmutant aamutational eventmutation type
ACGThrspl-2Spl.A->TTv

StructureKey Residue (HCD)Pyrimidin doubletCpG
 

Mutation impact


At the mRNA levelOn restriction map
r.9564_9649delNew restriction site(s): none
Lost restriction site(s): none

Impact on splicing
Splice site type Wild type sequence CV Mutant type sequence CV Variation (%)
Acceptor
tcttcataatagGG
82.5 _
tcttcataattgGG
53.6 _ *
-35.1 %

On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation)
Dp 427cDp 427mDp 427pDp 260Dp 140Dp 116Dp 71
       
Immunofluorescence
dys 1 dys 2 dys 3
   
Western Blot
dys 1 dys 2 dys 3
   

Patient and sample data


Sample IDPatient statusGenderTransmissionAge of onsetAge of deathGeographic origin
---255-4-51ProbandMaleFamilialFRANCE

Phenotypic group
 DMD

Reference


Reference IDPubMed IDReference
10015351422
Tuffery-Giraud S, Saquet C, Chambert S, Echenne B, Marie Cuisset J, Rivier F, Cossee M, Philippe C, Monnier N, Bieth E, Recan D, Antoinette Voelckel M, Perelman S, Lambert JC, Malcolm S, Claustres M. The role of muscle biopsy in analysis of the dystrophin gene in Duchenne muscular dystrophy: experience of a national referral centre. Neuromuscul Disord. 2004, 14(10):650-8.